VIVO BIO TECH LTD. - 511509 - Un-Audited Standalone & Consolidated Financial Statements Of The Company For The Second Quarter And Half Year Ended September 30, 2023
Vivo Bio Tech Limited has submitted with the exchange the Un-Audited Financial Results of the Company for the second quarter and half year ended September 30, 2023 VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Approval Of Un-Audited Standalone & Consolidated Financial Statements Of The Company For The Second Quarter And Half Year Ended September 30, 2023
Vivo Bio Tech Limited has informed the exchange about the Outcome of Board Meeting for Approval Of Un-Audited Standalone & Consolidated Financial Statements Of The Company For The Second Quarter and Half Year Ended September 30, 2023 VIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Second Quarter And Half-Year Ended September 30, 2023
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the Second Quarter and Half-Year ended September 30, 2023 VIVO BIO TECH LTD. - 511509 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Vivo Bio Tech Limited has submitted with the exchange the certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2023 VIVO BIO TECH LTD. - 511509 - Appointment Of Mr. Shyam Sunder Tipparaju As An Independent Director Of The Company
Vivo Bio Tech Limited has informed the exchange about the Appointment of Mr. Shyam Sunder Tipparajau as an Independent Director of the Company as approved by the shareholders in the 36th AGM held on 30.09.2023 VIVO BIO TECH LTD. - 511509 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Vivo Bio Tech Limited has submitted with the exchange the Scrutinizers Report and Voting Reults for business transacted at the 36th Annual General Meeting of the Company held on September 30, 2023. VIVO BIO TECH LTD. - 511509 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Vivo Bio Tech Limited has submitted with the exchange the Proceedings of the 36th Annual General Meeting of the Company held on Saturday, Septemebr 30, 2023 at 03.00 p.m. VIVO BIO TECH LTD. - 511509 - Closure of Trading Window
Vivo Bio Tech Limited has informed the exchange that, the Trading Window for dealing in securities of the Company shall remain closed for all insiders including Designated Persons and their immediate relatives from October 01, 2023 till the end of 48 hours after the declaration of the Un-Audited Financial Results of the Company for the second quarter and half year ended Septmber 30, 2023. VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Business Items Transacted/Approved On September 21, 2023
Vivo Bio Tech Limited has informed the exchange that with reference to the Company''s letter dated September 17, 2023, the Board of Directors of the Company at their meeting held today, i.e. Thursday, September 21, 2023, inter-alia, transacted the following business: 1. Approval for engagement/appointment of Consultants or Intermediaries for the proposed issuance of Equity Shares/Warrants by way of a Preferential Allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required. VIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Proposal For Preferential Issuance Of Equity Shares/Warrants
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2023 ,inter alia, to consider and approve VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2023 ,inter alia, to consider and approve 1. Proposal for issuance of equity shares/warrants by way of a preferential allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal of preferential allotment, as required.